We are live on ! Find out more
OCEA

Ocean Biomedical, Inc. Common Stock
OCEA

Delisted

OCEA was delisted on the 23rd of April, 2025.

Back to rankings

43 hedge funds and large institutions have $108M invested in Ocean Biomedical, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

8% more funds holding

Funds holding: 40 → 43 (+3)

2% more capital invested

Capital invested by funds: $106M → $108M (+$2.19M)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
43
Holders Change
+3
Holders Change %
+7.5%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
6
Closed
1
Calls
$146K
Puts
–
Net Calls
+$146K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
SFM
Spartan Fund Management
Canada
+$762K
2
HCM
Highbridge Capital Management
New York
+$446K
3
WAM
Warberg Asset Management
Illinois
+$347K
4
SOA
Sea Otter Advisors
Florida
+$257K
5
CSS
Cubist Systematic Strategies
Connecticut
+$120K

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$1.33M
2
CCM
Context Capital Management
California
-$339K
3
CH
CVI Holdings
Delaware
-$101K
4
KIM
Karpus Investment Management
New York
-$90.2K
5
WAM
Wolverine Asset Management
Illinois
-$58K
Name Holding Trade Value Shares
Change 		Change in
Stake
PSAMP
26
P. Schoenfeld Asset Management (PSAM)
New York
$835K – – –
LA
27
Linden Advisors
New York
$817K – – –
HCM
28
Highbridge Capital Management
New York
$815K +$446K +43,379 +124%
SFM
29
Spartan Fund Management
Canada
$771K +$762K +74,167 New
LCM
30
Landscape Capital Management
New Jersey
$759K +$4.11K +400 +0.6%
AI
31
Arena Investors
New York
$574K – – –
Walleye Capital
32
Walleye Capital
New York
$556K – – –
HF
33
HRT Financial
New York
$502K -$1.3K -127 -0.3%
DWM
34
Dakota Wealth Management
Florida
$448K – – –
AA
35
AQR Arbitrage
Connecticut
$430K – – –
CC
36
Centiva Capital
New York
$387K – – –
Walleye Trading
37
Walleye Trading
New York
$374K – – –
WAM
38
Warberg Asset Management
Illinois
$352K +$347K +33,809 New
EFI
39
EHP Funds Inc
Canada
$260K – – –
SOA
40
Sea Otter Advisors
Florida
$260K +$257K +25,000 New
Blackstone Inc
41
Blackstone Inc
New York
$151K – – –
CSS
42
Cubist Systematic Strategies
Connecticut
$122K +$120K +11,695 New
EC
43
Elequin Capital
New York
$2.69K – – –
WAM
44
Wolverine Asset Management
Illinois
– -$58K -5,742 Closed
1
2

OCEA Hedge Fund Activity: Q4 2022 in Review

43 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q4 2022, worth a combined $108M — up 2.1% from $106M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new OCEA positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 6 trimmed.

The largest buyer was Spartan Fund Management, opening a new position worth an estimated $762K. The largest seller was Periscope Capital, cutting an estimated $1.33M.

  • 43 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q4 2022, up from 40 in Q3 2022.
  • Funds reported $108M of Ocean Biomedical, Inc. Common Stock stock for Q4 2022, up 2.1% quarter-over-quarter.
  • 4 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q4 2022 and 1 closed out, a net change of +3 holders.
  • The largest Ocean Biomedical, Inc. Common Stock buyer in Q4 2022 was Spartan Fund Management, an estimated $762K added.
  • The largest Ocean Biomedical, Inc. Common Stock seller in Q4 2022 was Periscope Capital, an estimated $1.33M sold.

Based on aggregated 13F filings for Q4 2022.